The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
Abstract
Background— The increasing use of higher-than-approved doses of clopidogrel in clinical practice is based in part on the desire for greater levels of inhibition of platelet aggregation (IPA). Prasugrel is a new thienopyridine that is more potent than standard-dose clopidogrel in healthy subjects and patients with stable coronary artery disease. The relative antiplatelet effects of prasugrel versus high-dose clopidogrel in percutaneous coronary intervention patients are unknown. Methods and Results— Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 (PRINCIPLE-TIMI 44) was a randomized, double-blind, 2-phase crossover study of prasugrel compared with high-dose clopidogrel in patients undergoing cardiac catheterization for planned percutaneous coronary intervention. The primary end point of the loading-dose phase (prasugrel 60 mg versus clopidogrel 600 mg) was IPA with 20 μmol/L ADP at 6 hours. Patients with percutaneous coronary intervention entered the maintenance-dose phase, a 28-day crossover comparison of prasugrel 10 mg/d versus clopidogrel 150 mg/d with a primary end point of IPA after 14 days of either drug. In this study, 201 subjects were randomized. IPA at 6 hours was significantly higher in subjects receiving prasugrel (mean±SD, 74.8±13.0%) compared with clopidogrel (31.8±21.1%; P <0.0001). During the maintenance-dose phase, IPA with 20 μmol/L ADP was higher in subjects receiving prasugrel (61.3±17.8%) compared with clopidogrel (46.1±21.3%; P <0.0001). Results were consistent across all key secondary end points; significant differences emerged by 30 minutes and persisted across all time points. Conclusions— Among patients undergoing cardiac catheterization with planned percutaneous coronary intervention, loading with 60 mg prasugrel resulted in greater platelet inhibition than a 600-mg clopidogrel loading dose. Maintenance therapy with prasugrel 10 mg/d resulted in a greater antiplatelet effect than 150 mg/d clopidogrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationPrasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Self-citationBraunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Self-citationGuidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Self-citationCommittee Members, Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 845
Self-citationVariability in platelet responsiveness to clopidogrel among 544 individuals
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Bhatt, D. L., & Topol, E. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.067 · Cited by 777
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
Buonamici, P., Marcucci, R., Migliorini, A., Gensini, G. F., Santini, A., Paniccia, R., Moschi, G., Gori, A. M., Abbate, R., & Antoniucci, D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.094 · Cited by 656
Patti, G., Colonna, G., Pasceri, V., Pepe, L. L., Montinaro, A., & Di Sciascio, G. (2005) · Circulation · doi:10.1161/01.cir.0000161383.06692.d4 · Cited by 652
von Beckerath, N., Taubert, D., Pogatsa-Murray, G., Schömig, E., Kastrati, A., & Schömig, A. (2005) · Circulation · doi:10.1161/circulationaha.105.559088 · Cited by 623
Hochholzer, W., Trenk, D., Bestehorn, H.-P., Fischer, B., Valina, C. M., Ferenc, M., Gick, M., Caputo, A., Büttner, H. J., & Neumann, F.-J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.065 · Cited by 589
Self-citationBrandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., & Winters, K. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.010 · Cited by 571
Self-citationJernberg, T., Payne, C. D., Winters, K. J., Darstein, C., Brandt, J. T., Jakubowski, J. A., Naganuma, H., Siegbahn, A., & Wallentin, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi877 · Cited by 538
Self-citationClopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
Gurbel, P. A., Bliden, K. P., Samara, W., Yoho, J. A., Hayes, K., Fissha, M. Z., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.056 · Cited by 536
Montalescot, G., Sideris, G., Meuleman, C., Bal-dit-Sollier, C., Lellouche, N., Steg, P. G., Slama, M., Milleron, O., Collet, J.-P., Henry, P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.090 · Cited by 527
Self-citationWallentin, L., Varenhorst, C., James, S., Erlinge, D., Braun, O. O., Jakubowski, J. A., Sugidachi, A., Winters, K. J., & Siegbahn, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm545 · Cited by 457
Self-citationAngiolillo, D. J., Shoemaker, S. B., Desai, B., Yuan, H., Charlton, R. K., Bernardo, E., Zenni, M. M., Guzman, L. A., Bass, T. A., & Costa, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.667741 · Cited by 447
Self-citationACC/AHA/SCAI Practice Guidelines, February 21, 2006
(2006) · Circulation · doi:10.1161/circulationaha.106.173220 · Cited by 422
Hochholzer, W., Trenk, D., Frundi, D., Blanke, P., Fischer, B., Andris, K., Bestehorn, H.-P., Büttner, H. J., & Neumann, F. (2005) · Circulation · doi:10.1161/01.cir.0000160869.75810.98 · Cited by 398
Self-citationGurbel, P. A., Bliden, K. P., Hayes, K. M., Yoho, J. A., Herzog, W. R., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.030 · Cited by 381
Gurbel, P. A., Bliden, K. P., Zaman, K. A., Yoho, J. A., Hayes, K. M., & Tantry, U. S. (2005) · Circulation · doi:10.1161/01.cir.0000157138.02645.11 · Cited by 353
Smith, S., Feldman, T. E., Hirshfeld, J., Jacobs, A., Kern, M. J., King, S., Morrison, D. A., O'Neill, W. W., Schaff, H., Whitlow, P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1002/ccd.20606 · Cited by 328
Self-citationWiviott, S. D., Antman, E. M., Gibson, C. M., Montalescot, G., Riesmeyer, J., Weerakkody, G., Winters, K. J., Warmke, J. W., McCabe, C. H., & Braunwald, E. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.04.012 · Cited by 324
Self-citationFarid, N. A., Payne, C. D., Small, D. S., Winters, K. J., Ernest, C. S., Brandt, J. T., Darstein, C., Jakubowski, J. A., & Salazar, D. E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100139 · Cited by 323
Self-citationANGIOLILLO, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.036 · Cited by 303
Self-citationNiitsu, Y., Jakubowski, J. A., Sugidachi, A., & Asai, F. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869524 · Cited by 236
Self-citationSUGIDACHI, A., OGAWA, T., KURIHARA, A., HAGIHARA, K., JAKUBOWSKI, J. A., HASHIMOTO, M., NIITSU, Y., & ASAI, F. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02598.x · Cited by 220
Self-citationACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
(2004) · Circulation · doi:10.1161/circ.110.9.e82 · Cited by 215
von Beckerath, N., Kastrati, A., Wieczorek, A., Pogatsa-Murray, G., Sibbing, D., Graf, I., & Schömig, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl489 · Cited by 205
Clopidogrel Resistance: A New Chapter in a Fast-Moving Story
Wiviott, S. D., & Antman, E. M. (2004) · Circulation · doi:10.1161/01.cir.0000134701.40946.30 · Cited by 199
Self-citationKastrati, A., von Beckerath, N., Joost, A., Pogatsa-Murray, G., Gorchakova, O., & Schömig, A. (2004) · Circulation · doi:10.1161/01.cir.0000137972.74120.12 · Cited by 196
Payne, C. D., Li, Y. G., Small, D. S., Ernest, C. S., Farid, N. A., Jakubowski, J. A., Brandt, J. T., Salazar, D. E., & Winters, K. J. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181492209 · Cited by 167
Self-citationJakubowski, J. A., Matsushima, N., Asai, F., Naganuma, H., Brandt, J. T., Hirota, T., Freestone, S., & Winters, K. J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02792.x · Cited by 128
Self-citationClopidogrel Response Variability and Future Therapies: Clopidogrel: Does One Size Fit All?
O’Donoghue, M. L., & Wiviott, S. D. (2006) · Circulation · doi:10.1161/circulationaha.106.643171 · Cited by 121
Self-citationWolfram, R. M., Torguson, R., Hassani, S., Xue, Z., Gevorkian, N., Pichard, A. D., Satler, L. F., Kent, K. M., & Waksman, R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.064 · Cited by 40
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationPrasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Self-citationKushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Self-citation
Metadata
- Authors
- Wiviott, S. D., Trenk, D., Frelinger, A. L., O’Donoghue, M., Neumann, F.-J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., Jakubowski, J. A., Cairns, R., Murphy, S. A., McCabe, C. H., Antman, E. M., & Braunwald, E.
- Venue
- Circulation
- Published
- 2007-12-18
- Volume
- 116
- Issue
- 25
- Pages
- 2923-2932
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2152823642
- Cited by
- 881
- References
- 36
- FWCI
- 62.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.